Trans-Pacific Partnership Agreement Hits Turbulence Over Pharma IP Provisions
This article was originally published in PharmAsia News
Executive Summary
The nine countries negotiating the free trade agreement disagree on text for the intellectual property chapter; pharma continues to push for 12 years of biologics data exclusivity while generic associations oppose that and other IP proposals.